FSTL3 is increased in renal dysfunction

Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease

(2016) Olga A. Agapova et al.   KIDNEY INTERNATIONAL

Circulating progranulin but not renal progranulin expression is increased in renal dysfunction

(2015) Thomas Ebert et al.   KIDNEY INTERNATIONAL

Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice

(2015) Claus Brandt et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Metabolic functions of FABPs—mechanisms and therapeutic implications

(2015) Gökhan S. Hotamisligil et al.   Nature Reviews Endocrinology

Circulating adipocyte fatty acid-binding protein induces insulin resistance in micein vivo

(2015) Susan Kralisch et al.   Obesity

Relationship between Blood Myostatin Levels and Kidney Function:Shimane CoHRE Study

(2015) Shozo Yano et al.   PLoS One

Serum levels of the myokine irisin in relation to metabolic and renal function

(2014) Thomas Ebert et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus

(2014) T. Ebert et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction

(2014) T. Ebert et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

(2014)   Lancet Diabetes & Endocrinology

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction

(2013) Janka Hindricks et al.   CLINICAL ENDOCRINOLOGY

Obesity-related cardiorenal disease: the benefits of bariatric surgery

(2013) Wiebke Fenske et al.   Nature Reviews Nephrology

Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs

(2012) David Czock et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Serum Levels of the Adipokine Progranulin Depend on Renal Function

(2012) J. Richter et al.   DIABETES CARE

Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?

(2012) S. Kralisch et al.   DIABETOLOGIA

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Characterization of Follistatin-Type Domains and Their Contribution to Myostatin and Activin A Antagonism

(2012) Jennifer N. Cash et al.   MOLECULAR ENDOCRINOLOGY

Follistatin and Follistatin Like-3 Differentially Regulate Adiposity and Glucose Homeostasis

(2011) Melissa L. Brown et al.   Obesity

Effect of activin A on tubulointerstitial fibrosis in diabetic nephropathy

(2009) XIAO-JUN REN et al.   NEPHROLOGY

Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro

(2009) Susan Kralisch et al.   REGULATORY PEPTIDES

Hepatocyte Growth Factor/Activin A/Follistatin System Activation during Hemodialysis with Different Low Molecular Weight Heparins

(2009) Alicja Rydzewska-Rosołowska et al.   RENAL FAILURE

The Structure of FSTL3·Activin A Complex

(2008) Robin Stamler et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis

(2008) Michaela Ziegelmeier et al.   METABOLISM-CLINICAL AND EXPERIMENTAL